1. Home
  2. BOLT vs JCSE Comparison

BOLT vs JCSE Comparison

Compare BOLT & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

N/A

Current Price

$3.95

Market Cap

7.3M

Sector

Health Care

ML Signal

N/A

Logo JE Cleantech Holdings Limited

JCSE

JE Cleantech Holdings Limited

HOLD

Current Price

$1.45

Market Cap

7.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOLT
JCSE
Founded
2015
1999
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
7.1M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
BOLT
JCSE
Price
$3.95
$1.45
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$34.00
N/A
AVG Volume (30 Days)
11.5K
6.8K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
8.18%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,695,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$133.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.07
N/A
52 Week Low
$3.75
$0.77
52 Week High
$7.20
$2.50

Technical Indicators

Market Signals
Indicator
BOLT
JCSE
Relative Strength Index (RSI) 45.89 55.72
Support Level $3.87 $1.22
Resistance Level $4.46 $1.47
Average True Range (ATR) 0.22 0.10
MACD 0.01 0.00
Stochastic Oscillator 23.61 79.95

Price Performance

Historical Comparison
BOLT
JCSE

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company has two operating segments namely sale of cleaning systems and other equipment and provision of centralized dishware washing and general cleaning services. Geographically, the company derives a majority of its revenue from Singapore.

Share on Social Networks: